Cargando…
Antidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models
BACKGROUND & OBJECTIVES: Alteration in the serotonin leads to the psychological illness, such as depression, anxiety, schizophrenia, eating disorders, obsessive-compulsive disorder, panic disorders and migraines. The objective of the current study was to investigate the antidepressant and anxiol...
Autores principales: | Pandey, Dilip Kumar, Devadoss, Thangraj, Modak, Neha, Mahesh, Radhakrishnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345311/ https://www.ncbi.nlm.nih.gov/pubmed/28256473 http://dx.doi.org/10.4103/0971-5916.200893 |
Ejemplares similares
-
Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT(3) receptor antagonist: An investigation in behaviour-based rodent models of depression
por: Mahesh, Radhakrishnan, et al.
Publicado: (2012) -
Antidepressant Potential of 5-HT(3) Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n)
por: Mahesh, R, et al.
Publicado: (2012) -
Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): An approach using rodent behavioral antidepressant tests
por: Bhatt, Shvetank, et al.
Publicado: (2013) -
Antidepressant-like effect of a novel 5-HT(3) receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests
por: Kurhe, Yeshwant, et al.
Publicado: (2014) -
Pharmacological evaluation of novel 5-HT(3) receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery
por: Gupta, Deepali, et al.
Publicado: (2015)